SCM
Stonepine Capital Management Portfolio holdings
AUM
$102M
This Quarter Return
+9.04%
1 Year Return
+40.04%
3 Year Return
+160.28%
5 Year Return
+195.28%
10 Year Return
–
AUM
$185M
AUM Growth
+$185M
(+4.4%)
Cap. Flow
+$12.6M
Cap. Flow
% of AUM
6.82%
Top 10 Holdings %
Top 10 Hldgs %
70.79%
Holding
31
New
10
Increased
8
Reduced
8
Closed
3
Top Buys
| 1 |
Enanta Pharmaceuticals
ENTA
|
$11.1M |
| 2 |
Vanda Pharmaceuticals
VNDA
|
$10.5M |
| 3 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
$7.56M |
| 4 |
CUTR
Cutera, Inc.
CUTR
|
$4.53M |
| 5 |
NEOS
Neos Therapeutics, Inc
NEOS
|
$4.13M |
Top Sells
| 1 |
SCLN
Sciclone Pharmaceuticals Inc
SCLN
|
$15.9M |
| 2 |
ALR
Alere Inc
ALR
|
$8.78M |
| 3 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$7.34M |
| 4 |
CORV
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
|
$5.25M |
| 5 |
ALIM
Alimera Sciences, Inc.
ALIM
|
$3.33M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVE
1
DELISTED
VIVEVE MED INC
VIVE
| $27.5M | 14.86% | 3,849,711 | – | – |
|
|
2
Enanta Pharmaceuticals
ENTA
$180M
| $17.7M | 9.56% | 492,265 +307,166 | +166% | +$11.1M |
|
|
NVLN
3
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $17.1M | 9.23% | 1,852,395 +291,908 | +19% | +$2.69M |
|
|
SCTL
4
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $12.9M | 6.95% | 1,829,669 -1,044,648 | -36% | -$7.34M |
|
|
5
Vanda Pharmaceuticals
VNDA
$279M
| $11.2M | 6.03% | 685,086 +641,786 | +1,482% | +$10.5M |
|
6
Vericel Corp
VCEL
$1.83B
| $9.84M | 5.31% | 2,980,570 -284,753 | -9% | -$940K |
|
|
BDSI
7
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $9.74M | 5.26% | 3,477,673 +632,853 | +22% | +$1.77M |
|
|
ISEE
8
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $9.16M | 4.94% | 3,576,189 +59,700 | +2% | +$153K |
|
|
AVDL
9
Avadel Pharmaceuticals
AVDL
$1.43B
| $8.25M | 4.45% | 747,863 -4,547 | -0.6% | -$50.2K |
|
10
Cumberland Pharmaceuticals
CPIX
$52.2M
| $7.76M | 4.19% | 1,109,167 +369,250 | +50% | +$2.58M |
|
|
CTIC
11
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $7.56M | 4.08% | +2,284,381 | New | +$7.56M |
|
|
CORV
12
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $7.21M | 3.89% | 1,595,549 -1,161,711 | -42% | -$5.25M |
|
13
Veracyte
VCYT
$2.39B
| $7.2M | 3.89% | 864,695 +286,495 | +50% | +$2.39M |
|
|
ALR
14
DELISTED
Alere Inc
ALR
| $5.02M | 2.71% | 100,000 -175,000 | -64% | -$8.78M |
|
15
DURECT Corp
DRRX
$59.6M
| $4.96M | 2.68% | 3,175,994 +374,618 | +13% | +$584K |
|
|
CUTR
16
DELISTED
Cutera, Inc.
CUTR
| $4.53M | 2.45% | +175,000 | New | +$4.53M |
|
|
NEOS
17
DELISTED
Neos Therapeutics, Inc
NEOS
| $4.13M | 2.23% | +565,100 | New | +$4.13M |
|
|
CORI
18
DELISTED
Corium International, Inc.
CORI
| $3.09M | 1.67% | +413,568 | New | +$3.09M |
|
|
BSTC
19
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $2.97M | 1.6% | +59,878 | New | +$2.97M |
|
|
SCLN
20
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| $2.38M | 1.28% | 216,307 -1,446,974 | -87% | -$15.9M |
|
|
TRIB
21
Trinity Biotech
TRIB
$5.44M
| $1.87M | 1.01% | 311,994 -39,923 | -11% | -$240K |
|
22
Assertio
ASRT
$80.4M
| $1.36M | 0.73% | +126,600 | New | +$1.36M |
|
|
CASM
23
DELISTED
CAS Medical Systems, Inc.
CASM
| $1.04M | 0.56% | +900,366 | New | +$1.04M |
|
|
AMRN
24
Amarin Corp
AMRN
$311M
| $302K | 0.16% | +75,000 | New | +$302K |
|
|
ALIM
25
DELISTED
Alimera Sciences, Inc.
ALIM
| $257K | 0.14% | 184,827 -2,391,446 | -93% | -$3.33M |
|